Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
COSTA MESA, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bastion, today announced the appointment of Jody Sowa as Managing Director, Public Relations in the United States, strengthening the company’s...
Read More -
As the holiday season intensifies feelings of loss, Dianetics provides an avenue for relief and renewed joy for those coping with grief.
Read More
-
DUBAI, United Arab Emirates, Dec. 11, 2025 (GLOBE NEWSWIRE) -- A fast-rising project in the DeFi sector is now approaching one of the most important milestones in its development. Mutuum Finance...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
-
Copenhagen Airports A/S hereby announces that the company has today received the attached notice from the Kingdom of Denmark via the Ministry of Finance. The notice informs the shareholders of...
-
Keiretsu Forum MST and MDB Capital united 150+ investors to improve syndication and exits, and will expand the Investor Summit series nationwide in 2026.
-
Jefferies Financial Group Inc. Stock Dropped 8% Leading to Securities Fraud Investigation; Contact BFA Law if You Lost Money
-
COSTA MESA, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bastion, today announced the appointment of Jody Sowa as Managing Director, Public Relations in the United States, strengthening the company’s...
-
Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...
-
Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial KT-621 BROADEN2 Phase 2b AD trial ongoing, with data expected to be...
-
STAMFORD, Conn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The...
-
The results show, for the first time, that targeting a-syn pathology with an active immunotherapy could potentially slow the rate of progression of PD.